共 50 条
Carboplatin Dosing in Children: Calculation by Different Formulae
被引:0
|作者:
Wuerthwein, Gudrun
[2
]
Krefeld, Barbara
[1
]
Gerss, Joachim
[3
]
Boos, Joachim
[1
]
机构:
[1] Univ Klinikum Munster, Klin & Poliklin Kinderheilkunde Padiatr Hamatol O, D-48129 Munster, Germany
[2] ZKS, Freiburg, Germany
[3] Univ Klinikum Munster, Abt Med Informat & Biomath, Munster, Germany
来源:
ONKOLOGIE
|
2011年
/
34卷
/
1-2期
关键词:
Carboplatin;
Dose calculation;
Children;
GLOMERULAR-FILTRATION-RATE;
BODY-SURFACE AREA;
SERUM CREATININE;
POPULATION PHARMACOKINETICS;
PLASMA CREATININE;
RENAL-FUNCTION;
SOLID TUMORS;
PHASE-I;
WEIGHT;
HEIGHT;
D O I:
10.1159/000323369
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background: Carboplatin dosing in children is based on renal function and there exists a wealth of formulae available for calculating the body surface area (BSA), the glomerular filtration rate (GFR), and the carboplatin dose. Patients and Methods: A fictitious group of children with different ages and body builds was 'constructed'. For comparison of formulae, bias and precision were assessed. Results: BSA calculations according to DuBois-DuBois, Gehan-George, Mosteller, and Boyd showed good agreement. GFR calculations according to the weight-based Cole formula and the Leger formula gave comparable results. Regarding GFR in young children, the weight- and creatinine-based Cole and the Schwartz formula showed clear differences. Again, carboplatin dose calculations according to Marina, Newell, and Chatelut are comparable. Moreover, the precision of the creatinine measurement has a clear influence on the result of the dose calculation. Conclusions: The choice of the GFR formula is more important for the carboplatin dose calculation compared to the BSA or dose equation. GFR calculations in children show marked, age-dependent variations. A sequence of multiple calculation steps (especially for the Schwartz and Marina formulae) may lead to considerable uncertainty and proneness to error in the clinical routine. In high-risk patients, GFR should be measured precisely and complemented by therapeutic drug monitoring.
引用
收藏
页码:16 / 22
页数:7
相关论文